Castleark Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GF
FLAM
Castleark Management's NEO Position: Q3 2023 in Review
Castleark Management sold out of NeoGenomics (NEO) in Q3 2023, closing a stake of 262,507 shares — an estimated $4.22M sold.
Castleark Management first reported a position in NEO in Q3 2013 and held it in 18 quarters. The position peaked at $13.5M in Q1 2019. 284 funds tracked by Wall St. Rank hold NEO as of Q3 2023.
- Castleark Management reported no remaining NeoGenomics position as of Q3 2023 after selling out during the quarter.
- Castleark Management sold 262,507 NeoGenomics shares in Q3 2023, an estimated $4.22M.
- Castleark Management first reported a position in NeoGenomics in Q3 2013 and held it in 18 quarters.
- Castleark Management's NeoGenomics position peaked at $13.5M in Q1 2019.
- 284 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2023.
Based on Castleark Management's 13F filing for Q3 2023, filed 15 Nov 2023.